Offer - Urjas Oil for just ₹ 1 X
Jubiglim MV 2 Tablet SR is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Diabetes.
The right dosage of Jubiglim MV 2 Tablet SR depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Jubiglim MV 2 Tablet SR can also lead to other problems, which have been listed below. Usually, these side effects of Jubiglim MV 2 Tablet SR go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Jubiglim MV 2 Tablet SR's effect is Moderate during pregnancy and Unknown for lactating mothers. Warnings related to Jubiglim MV 2 Tablet SR's effects on the liver, heart and kidney, if any, have been listed below.
Jubiglim MV 2 Tablet SR is contraindicated in people with pre-existing medical conditions like Heart Disease, Liver Disease, Kidney Disease as it can result in adverse effects. Other contraindications of Jubiglim MV 2 Tablet SR have been discussed in the sections ahead.
Additionally, Jubiglim MV 2 Tablet SR may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Jubiglim MV 2 Tablet SR, it is important to know that it is safe while driving, and is habit-forming.
Jubiglim MV 2 Tablet SR is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Jubiglim MV 2 Tablet SR safe for pregnant women?
Jubiglim may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Jubiglim again without your doctor's advice.
Is the use of Jubiglim MV 2 Tablet SR safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Jubiglim for breastfeeding women are not known.
What is the effect of Jubiglim MV 2 Tablet SR on the Kidneys?
Jubiglim can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Jubiglim MV 2 Tablet SR on the Liver?
You may experience side effects on your liver after taking Jubiglim. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Jubiglim MV 2 Tablet SR on the Heart?
Jubiglim has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Jubiglim MV 2 Tablet SR unless your doctor advises you to do so -
Is this Jubiglim MV 2 Tablet SR habit forming or addictive?
Forming a habit of Jubiglim MV 2 Tablet SR has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Jubiglim MV 2 Tablet SR does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but take Jubiglim MV 2 Tablet SR only as per medical advice.
Is it able to treat mental disorders?
No, the use of Jubiglim MV 2 Tablet SR in mental disorders is not effective.
Interaction between Food and Jubiglim MV 2 Tablet SR
Due to the absence of research, it is difficult to say how Jubiglim MV 2 Tablet SR and food will interact.
Interaction between Alcohol and Jubiglim MV 2 Tablet SR
Taking alcohol with Jubiglim MV 2 Tablet SR can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158